Hans Hofland

Hans Hofland is a seasoned professional in the field of pharmaceutical technology, holding a PhD from Leiden University obtained between 1987 and 1992. Currently serving as the SVP of Preclinical Development at Turn Biotechnologies and previously as President of SF Bay BioInsights Consulting, LLC, Hofland also co-founded Evommune, where the role of Co-Founder and Senior Vice President of Research was undertaken. Prior experience includes serving as VP of Research and Nonclinical Development at Dermira, Inc. and as Sr. Director of Pharmacology & Skin Biology at Stiefel, a GSK company.